United States

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 11, 2019

  

CHINA JO-JO DRUGSTORES, INC.

(Exact name of Registrant as specified in charter)

 

Nevada   001-34711   98-0557852
(State or other jurisdiction of Incorporation)   (Commission File No.)   (IRS Employer Identification No.)

 


Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District,

Hangzhou City, Zhejiang Province, People’s Republic of China, 310008

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code: +86-571-88219579

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17CFR230.425)

 

☐ Soliciting material pursuant to Rule14a-12 under the Exchange Act (17CFR240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

  

 

 


Item 5.07 Submission of Matters to a Vote of Security Holders.

 

On March 11, 2019, China Jo-Jo Drugstores, Inc. (the “Company”) held its annual meeting of shareholders for its fiscal year ended March 31, 2018. A quorum was present at the meeting as required by the Bylaws of the Company, as amended. The final voting results for each matter submitted to a vote of shareholders at the meeting are as follows. No broker non-votes were counted for any of the proposals as the Company chose to.

 

1. A proposal to elect six directors to the registrant’s board of directors to hold office until the next annual meeting and until their successors are duly elected and qualified:

 

Director’s Name   Votes For    Votes Against 
Lei Liu   20,069,817    18,111 
Li Qi   20,069,537    18,391 
Caroline Wang   19,691,437    396,491 
Jiangliang He   20,084,817    3,111 
Genghua Gu   19,691,717    396,211 
Pingfan Wu   20,084,817    3,111 

 

2. A proposal to ratify the appointment of BDO CHINA SHU LUN PAN Certified Public Accountants LLP as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2019:

 

For   Against   Abstain 
 20,087,088    305    535 

 

Pursuant to the foregoing votes, Lei Liu, Li Qi, Caroline Wang, Jiangliang He, Genghua Gu and Pingfan Wu were elected to serve as directors and BDO CHINA SHU LUN PAN Certified Public Accountants LLP was ratified as the registrant’s independent registered public accounting firm for the fiscal year ending March 31, 2019.

 

 1 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  

Date: March 13, 2019 CHINA JO-JO DRUGSTORES, INC.
   
  By:  /s/ Lei Liu
 

Name:

Title:

 Lei Liu
Chief Executive Officer

 

 

 2